Job Summary:
The SVP, Software Engineering is responsible for defining and leading Masimo's global software engineering strategy, execution, and organizational capability across all software domains, including embedded systems, cloud platforms, applications, and enterprise systems. This role provides executive leadership over software architecture, development, validation, and delivery, ensuring alignment with business priorities, product innovation, and regulatory requirements. The SVP drives the evolution of scalable, high-quality software solutions, establishes engineering excellence, and builds a high-performing organization to support Masimo's growth and technology leadership.
Duties & Responsibilities:
Minimum Qualifications:
Preferred Qualifications:
Education:
Language requirements:
Compensation:
The anticipated salary range for this position is $272,000 - $370k plus benefits. Actual placement within this range is dependent on multiple factors, including but not limited to skills, education, and experience. This position also qualifies for up to 35% annual bonus based on company, department, and individual performance.
Physical requirements/Work Environment:
This position primarily works in an office environment and requires frequent sitting, standing, and walking. Daily use of a computer and other digital devices is required. This role may require standing for extended periods when facilitating meetings or walking through facilities.
The physical demands of the position described herein are essential functions of the job and employees must be able to successfully perform these tasks for extended periods. Reasonable accommodations may be made for those individuals with real or perceived disabilities to perform the essential functions of the job described.
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb™) monitoring technology. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities.